Interpharm Holdings, Inc.

Type: Public
On the web: http://www.interpharminc.com
Employees: 670

Interpharm Holdings makes, and markets generic prescription and over-the counter drugs. It makes about a dozen different generic drugs -- including acetaminophen, hydrocodone, and ibuprofen -- in various dosage strengths. Interpharm sells many of its products directly to major chains, wholesalers, and others, both under its own name and private labels. Through an agreement with Centrix Pharmaceutical, it makes a female hormone product that Centrix distributes in the US. Interpharm is trying to expand its product line in a number of areas, including hormones, scheduled narcotics, and specialized drug delivery products such as soft gels and liquids. Chairman Maganlal Sutaria and family control the company.

Key numbers for fiscal year ending June, 2007:
Sales: $75.6M
One year growth: 19.3%
Net income: ($14.1)M

Officers:
Chairman: Maganlal K. Sutaria
CEO: Cameron Reid
EVP Sales and Marketing: Jeffrey Weiss

Competitors:
Sandoz International GmbH
Teva Pharmaceuticals
Watson Pharmaceuticals

ADVERTISEMENT